Cathie Wood Nurix Therapeutics, Inc. Transaction History

Ark Investment Management LLC

$12.1 Billion
Q2 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 1,575,032 shares of NRIX stock, worth $15.8 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,575,032

Previous 1,590,910 1.0%

Holding current value

$15.8 Million

Previous $18.9 Million 5.08%

% of portfolio

0.15%

Previous 0.2%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$8.81 - $12.79 $139,885 - $203,079	-15,878 Reduced 1.0%	1,575,032 $17.9 Million
Q1 2025 May 07, 2025	BUY	$11.88 - $20.15 $720,129 - $1.22 Million	60,617 Added 3.96%	1,590,910 $18.9 Million
Q4 2024 Feb 04, 2025	SELL	$18.64 - $28.14 $12.8 Million - $19.3 Million	-686,072 Reduced 30.95%	1,530,293 $28.8 Million
Q3 2024 Oct 31, 2024	SELL	$18.93 - $25.69 $2.02 Million - $2.75 Million	-106,967 Reduced 4.6%	2,216,365 $49.8 Million
Q2 2024 Jul 26, 2024	SELL	$12.02 - $21.3 $3.75 Million - $6.65 Million	-312,006 Reduced 11.84%	2,323,332 $48.5 Million
Q1 2024 Apr 18, 2024	SELL	$7.77 - $15.66 $4.35 Million - $8.76 Million	-559,661 Reduced 17.52%	2,635,338 $38.7 Million
Q4 2023 Jan 17, 2024	BUY	$4.25 - $10.71 $2.56 Million - $6.45 Million	601,952 Added 23.21%	3,194,999 $33 Million
Q3 2023 Oct 18, 2023	BUY	$7.86 - $10.08 $2.61 Million - $3.35 Million	331,976 Added 14.68%	2,593,047 $20.4 Million
Q2 2023 Jul 10, 2023	BUY	$8.7 - $13.28 $184,544 - $281,695	21,212 Added 0.95%	2,261,071 $22.6 Million
Q1 2023 Apr 17, 2023	BUY	$8.56 - $13.26 $2.15 Million - $3.34 Million	251,605 Added 12.65%	2,239,859 $19.9 Million
Q4 2022 Jan 24, 2023	BUY	$9.86 - $14.59 $6.92 Million - $10.2 Million	701,732 Added 54.54%	1,988,254 $0
Q3 2022 Oct 17, 2022	BUY	$12.33 - $19.81 $6.26 Million - $10.1 Million	507,797 Added 65.21%	1,286,522 $16.8 Million
Q2 2022 Jul 11, 2022	BUY	$7.88 - $14.82 $3.05 Million - $5.73 Million	386,734 Added 98.66%	778,725 $7.86 Million
Q1 2022 Apr 19, 2022	BUY	$12.94 - $29.65 $4.5 Million - $10.3 Million	348,044 Added 791.96%	391,991 $5.49 Million
Q4 2021 Jan 28, 2022	BUY	$26.43 - $34.5 $1.16 Million - $1.52 Million	43,947 New	43,947 $1.27 Million

Others Institutions Holding NRIX

# of Institutions

178

Shares Held

75.9M

Call Options Held

56.9K

Put Options Held

7.9K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $472M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account